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Abstract
Background: Aim of this retrospective study was to describe clinical characteristics, diagnostic work-up,
management and follow-up of newborns with neural tube defects (NTDs), admitted to the Mother and Child
Department of the University Hospital of Palermo, in a ten years period.
Methods: The medical records of 7 newborns (5 males and 2 females) admitted, over a 10-year period from
January 2010 to March 2020, to our Department on the first day of life were reviewed. Analyzed data were related
to familiar and/or maternal risk factors (consanguinity, maternal preexisting and/or gestational diseases, exposure to
teratogen/infectious agents, lack of preconception folic acid supplement), demographic (ethnicity/origin, residence)
and clinical features (eventual use of assisted reproduction techniques, prenatal diagnosis, gestational age, fetal
presentation, type of delivery, birth weight, preoperative imaging, antibiotics and analgesics use, description of the
surgery intervention, length of hospital stay, comorbidities, complications), and follow-up.
Results: In our sample we observed a wide spectrum of NTDs: 3 newborns had open NTDs, namely
myelomeningocele (2 lumbosacral, one of which associated with extradural lipoma, and 1 sacral), and 4 closed
ones, including 2 with meningocele (occipital), 1 filar lipoma associated with dermal sinus, and 1 terminal
myelocystocele. Our patients were discharged between 8 and 22 days of life.
The neurodevelopmental follow-up showed a favorable outcome for 4 of the 7 patients, and the appearance over
time of neurological impairment (motor and/or autonomic) in the newborns with open NTDs.
Conclusions: This study describes familiar and/or maternal risk factors and demographic and clinical features of a
single-center series of newborns with NTDs. It may provide a further outline of the actual phenotypic spectrum of
these malformations, and new insights into epidemiological aspects and comprehensive management of the
patients, including diagnostic work-up and follow-up evaluations.
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Background
Neural tube defects (NTDs) are congenital malforma-
tions of the central nervous system [1]. They are caused
by partial/incomplete closure of the neural tube during
embryogenesis, between 21 and 28 days after conception
[2, 3]. Disorders of primary neurulation include cranior-
achischisis in which the neural tube fails to initiate clos-
ure, leaving most of the brain and the entire spine open.
If closure initiates successfully, then the cranial and/or
spinal neural folds may fail to close generating exence-
phaly/anencephaly and open spina bifida (myelomenin-
gocele). Malformations resulting from disturbance of
secondary neurulation are closed (skin covered) and
often involve tethering of the spinal cord, with associ-
ated ectopic lipomatous material [4, 5]. Nevertheless, re-
cent evidences support a post-neurulation origin for
encephalocele and demonstrate that brain herniation
and failure of brain/spine neural tube closure can all
occur as possible developmental outcomes of an identi-
cal genetic defect [6]. Infants with anencephaly are
mostly stillborn, or die shortly after birth, while those
with spina bifida and encephalocele may survive, al-
though suffering from physical and developmental dis-
abilities of various degrees of severity [7]. Worldwide
average incidence is 1.8/1000 births (more than 300,000
affected infants born every year), with significant geo-
graphic (ethnic, environmental, socioeconomic) varia-
tions (> 1 to around 10/1000 births in middle and low-
income countries (LMICs) and decreasing incidence in
high-income countries (HICs, 0.6/1000 in USA) in the
recent decades [8, 9].
NTDs are among the main causes of childhood mor-
tality and disability worldwide, with higher rates in
LMICs for limited access to specialized neonatological/
pediatric and surgical care [8–10]. Moreover, inequities
in the access to high quality care affect pregnant/child-
bearing age women [11], in relation to low rate of pre-
natal diagnosis and prevention tools (preconception folic
acid supplement), thus explaining the higher prevalence
of NTDs at birth.
Here we report on a ten years retrospective study of
newborns with NTDs assisted at the Mother and Child
Department of the University Hospital of Palermo (Si-
cily, Italy). The aim of the study was to describe epi-
demiological aspects and clinical characteristics of these
patients, as well as diagnostic work-up, comprehensive
management and updated follow-up. To the best of our
knowledge, our report is the first in Western Sicily con-
cerning these malformations.
Methods
Patients
This is a retrospective study, conducted over a 10-year
period from January 2010 to March 2020, on all
newborns with neural tube defects (NTDs) admitted to
the Mother and Child Department of the University
Hospital of Palermo (Sicily, Italy). Our Department in-
cludes 3 Operative Units: Obstetrics and Gynecology,
Neonatology and Neonatal Intensive Care and Pediatric
Surgery. The latter is one of the few in Sicily (which is
among the most populated Italian regions, with around
5 million inhabitants and 40,000 newborns estimated in
2019) to take care of these malformations. In the decade
under investigation, the catchment population of our
Department (spanning almost all Western Sicily, i.e. the
provinces of Agrigento and Caltanissetta besides that of
Palermo) was of about 175.000 newborns.
Data collected by neonatal records and follow-up
charts were related to familiar and/or maternal risk fac-
tors (consanguinity, maternal preexisting and/or gesta-
tional diseases, exposure to teratogen/infectious agents,
lack of preconception folic acid supplement), demo-
graphic (ethnicity/origin, residence), clinical features
(eventual use of assisted reproduction techniques, pre-
natal diagnosis, gestational age, fetal presentation, type
of delivery, birth weight, preoperative imaging, modal-
ities of pharmacological prophylaxis and/or therapy with
antibiotics and analgesics, description of the surgery
intervention, length of hospital stay, comorbidities, com-
plications), and neurodevelopmental outcomes. Ethical
approval was granted from the Ethics Committee of our
University Hospital.
Results
Seven patients were included in this study (5 males and
2 females). All of them were admitted on the first day of
life, 4 inborn, and 3 were transferred from other first
level birth centers.Ethnicity was Sicilian for all newborns
except for one, whose parents were from Ghana.
No consanguinity was found in any case. Five fam-
ilies lived in the urban area and two came from a
rural area. All patients were naturally conceived. Two
women with preexisting diseases were observed, one
with severe obesity, and the other with HIV infection.
No mother received preconception folic acid supple-
ment, and only one woman took folate during preg-
nancy. A prenatal diagnosis was performed in only 2
(1 lumbosacral myelomeningocele, and 1 terminal
myelocystocele) of 7 subjects. All newborns, except
one (35 WG), were at term. All had cephalic presen-
tation. Four were born by vaginal delivery (one of
which was precipitous), and 3 by caesarean section.
Two were low-birth-weight infants (< 2500 g). The
length of hospitalization ranged from 8 to 22 days.
Clinical features
A wide spectrum of NTDs was observed in our patients:
three had open NTDs, namely myelomeningocele
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(MMC, 2 lumbosacral, one of which associated with
extradural lipoma and concomitant split cord malforma-
tion, and 1 sacral), and 4 closed ones, including 2 with
occipital meningocele, 1 filar lipoma associated with der-
mal sinus, and 1 terminal myelocystocele. Three patients
had associated anomalies and/or comorbidities: 1 cere-
bellar and corpus callosum hypoplasia and feet deform-
ities, with normal array comparative genomic
hybridization (a-CGH) findings, 1 hypospadias, and 1
HIV infection, severe perinatal asphyxia, and congenital
microcephaly (head circumference below 2 SD). Images
related to the newborn with MMC and split cord mal-
formation are showed in Fig. 1.
Medical imaging
All patients performed in the first days of life ultrasound
(US) examinations of brain, skin and soft tissues over
the spine, abdomen and heart. The newborn affected by
filar lipoma performed also lumbosacral X-ray. In the
two patients with occipital meningocele, Computed
Tomography (CT) of the head in one case, and brain
and spine Magnetic Resonance Imaging (MRI) in the
other one, were performed to rule out a cerebral paren-
chymal involvement. Ophthalmological evaluation was
performed in both of them. In the 2 newborns with
MMC, cerebral US showed triventricular hydrocephalus
along with cerebellar and corpus callosum hypoplasia in
one subject, and isolated non progressive enlargement of
the lateral ventricles in the other one. In the patient with
myelocystocele an isolated cavitation of choroid plexus
was observed.
Treatment and neurodevelopmental outcomes
A surgical procedure was performed in 5 of the 7 pa-
tients in neonatal age within 72 h of life, 3 with open
NTDs and two with occipital meningocele. In three new-
borns with MMC, it consisted of a direct approach, pre-
serving maximum healthy skin to allow a closure of the
defect. An incision between the dura mater and the skin
around the neural placode was performed. A progressive
dissection and identification of the meningeal plan, until
the basis of the bone cleft, was made. An opening of the
dural sac was carried out, then the dura was sutured
with very fine polydioxanone continuous suture before
skin closure. One of these three patients underwent a
contextual excision of a lipomatous extradural lesion in
the upper third of the defect, another one a simultan-
eous ventriculoperitoneal shunting for concomitant
hydrocephalus, and the third an additional lateral relax-
ing incisions in the fascia for primary skin defect closure.
In the newborns with occipital meningocele, the inter-
vention consisted of a simple section of the defect on its
basis, with covering of the bone abnormality with sur-
rounding tissue, and then closure of the scalp. All pa-
tients underwent parenteral antibiotic prophylaxis and
analgesic therapy during surgical procedures and, except
for the preterm one, who was further supported by
mechanical ventilation, they were spontaneously breath-
ing at the end of operating session.
The postoperative evolution was uneventful in all
cases, with the exception of a newborn with MMC suf-
fering from a surgical wound dehiscence, that healed in
10 days. No deaths occurred in the present case series.
At follow-up, the two patients with MMC presented
with the expected severe neurological impairment re-
lated to the spinal segment involvement above L3. A fe-
male patient aged 5 years, with concomitant cerebral
anomalies, is also affected by a global developmental
delay. The youngest patient with MMC, aged two
months, has a reduced motility of lower limbs and fecal
incontinence and no cerebral ventricular dilatation. The
preterm patient with lumbosacral spina bifida, aged 5
years, achieved autonomic walking at two years of age,
normal urinary and fecal continence, and shows a nor-
mal cognitive developmental level. The third newborn
with MMC and associated extradural lipoma, does not
have a significant follow-up time (as she currently is 3
months old), and actually shows hypoesthesia and
Fig. 1 Female neonate with lumbosacral lipomyelomeningocele (a); an associated split cord malformation was evident during surgery (b)
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reduced motility of the lower limbs. The male patient
with isolated occipital meningocele underwent surgical
correction at three months of age, and now, aged 7 years,
has a normal neurodevelopmental profile. The male in-
fant with filar lipoma and dermal sinus at three months
of age shows a normal lower limbs motility and fecal
continence. He has not yet been operated, in relation to
the parental will to wait for a greater age. The patient
with terminal myelocystocele was operated at three
months of age, and now, aged 10 years, he has a normal
global neurodevelopmental profile. Epidemiological and
clinical data are summarized in Tables 1 and 2.
Discussion
The term “spina bifida” was first coined in 1641 by
Nicholas Tulp [12]. The spread of surgical treatment of
open NTDs and the knowledge of pathophysiology (in-
cluding primary prevention through folic acid precon-
ception supplement), epidemiology and genetics of such
defects were reached much later, in the late twentieth
century [9].
Most NTDs are sporadic and multifactorial: an oligo-
genic/polygenic inheritance (genes regulating folate and
methionine metabolism, and others involved in planar
cell polarity signaling pathway) interact with influencing
environmental factors [4, 5, 13]. Risk factors include:
maternal folate deficiency, diabetes, obesity, exposure to
teratogens (valproic acid and carbamazepine, lead and
tetrachloroethylene-contaminated drinking water, ar-
senic, pesticides, mycotoxins, fungus contaminants of
maize, heat, influenza virus), specific parental occupa-
tions and low socioeconomic status [4, 14]. Recurrence
risk of a second affected child is increased by 3–5 folds
for couples with one sick infant, compared to the general
population. A significant proportion (10%) of NTDs are
associated with syndromes and/or chromosomal anom-
alies/congenital malformations, and the correlation is
more marked (20%) in some ethnic groups (i.e. Arab
populations with increased prevalence of autosomal re-
cessive diseases, reflecting their high coefficient of
consanguinity) [15]. Associated conditions included are:
VACTERL association (vertebral abnormalities, anal
atresia, cardiac defects, tracheal anomalies including
tracheo-esophageal fistula, esophageal atresia, renal
anomalies, limb anomalies, MIM:192350), amniotic band
sequence, Currarino syndrome (a peculiar form of cau-
dal regression syndrome, also known as autosomal dom-
inant sacral agenesis, MIM:176450), Waardenburg
syndrome, Joubert syndrome, Meckel-Gruber syndrome
and some chromosomal abnormalities like trisomy 13,
trisomy 18, triploidy and partial aneuploidy [16].
The low number of patients affected/families involved
limited the diagnostic efficacy of genetic analysis. How-
ever, whole genome sequencing techniques found candi-
date NTDs loci and genes in chromosomes 2, 7, 10 and
17 (some of which, i.e. WIPI1, SPHKAP and NCOR1,
have recently been associated with anencephaly) [7, 16].
These insights add to our existing knowledge of the gen-
etic mechanisms underlying NTDs development [17].
Table 1 Epidemiological data of present patients
SEX • 5 males
• 2 females
TYPE OF ADMISSION • 4 inborn
• 3 outborn
ORIGIN (ethnicity) • 6 Sicilian (European)
• 1 Ghanaian (African)
RESIDENCE • 5 urban area
• 2 rural area
PREEXISTING MATERNAL DISEASES • 1 severe obesity
• 1 HIV infection
FOLIC ACID SUPPLEMENT • 0 preconception
• 1 gestational
Table 2 Clinical characteristics of present patients
PRENATAL DIAGNOSIS 2/7 newborns
• 1 lumbosacral myelomeningocele
• 1 terminal myelocystocele
GESTATIONAL AGE • 6 at term
• 1 preterm (35 WG)
TYPE OF DELIVERY • 4 vaginal (1 precipitous)
• 3 cesarean section
TYPE OF NEURAL TUBE DEFECT • 3 open: MMC, 2 lumbosacral, one
of which associated with extradural
lipoma, and 1 sacral
• 4 closed: 2 occipital meningocele,
1 filar lipoma associated with dermal
sinus, 1 terminal myelocystocele
ASSOCIATED ANOMALIES AND/
OR COMORBIDITIES
3/7 newborns
• 1 cerebellar and corpus callosum
hypoplasia and feet deformities,
with normal a-CGH findings
• 1 hypospadias
• 1 HIV infection, severe perinatal
asphyxia, and congenital
microcephaly (< −2SD)
MEDICAL IMAGING/SPECIALISTIC
EVALUATIONS
• 7/7 US of brain, skin and soft tissues
over the spine, abdomen and heart
• 1/7 lumbosacral X-ray
• 1/7 CT of the head
• 1/7 brain and spine MRI
• 2/7 ophthalmological evaluation
SURGICAL PROCEDURE 5/7 newborns
• 3 MMC
• 2 meningocele
POSTOPERATIVE EVOLUTION • 4/5 uneventful
• 1/5 surgical wound dehiscence
NEURODEVELOPMENTAL
OUTCOMES
• 3 normal neurodevelopmental
profile and/or normal lower limbs
motility and fecal continence
• 2 severe neurological impairment
• 1 global developmental delay
• 1 reduced motility of lower limbs
and fecal incontinence
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The ongoing genomic revolution will indeed offer the
possibility to carry out genomic projects, with the aim of
identifying new variants implicated in the biologic basis
of NTDs [16–18].
The low rate of NTDs observed in our case series,
even more marked than that currently found in HICs [8,
19–21], may be explained by some plausible factors: a
likely high number of prenatal diagnoses and abortions
in our setting, and the phenomenon of health emigration
(from Sicily to central-northern Italian regions), that
may have contributed to the reduction/underestimation
of our cases.
A large number of studies provided evidence that
folate fortification reduces the incidence of MMC and
anencephaly (conditions known as folic acid prevent-
able spina bifida, FAP-SB, which represent up to 92%
of all NTDs) [9, 22–24]. In USA preventive policies
were first implemented in 1992, with a recommenda-
tion by the Public Health Service, that all women of
childbearing age should consume 400 μg of folic acid
daily [9]. In 1998, mandatory fortification of enriched
cereal grain products was instituted, whose adoption
resulted in a 28% reduction in NTDs prevalence
(from 10.7 cases/1000 in 1992 to 7/1000 in 1998) [9].
However, after the initial reduction, birth prevalence
remained stable since 1999, with nearly a quarter
(21.6%) of childbearing age women who still have low
red blood folate concentration associated with a
higher risk for NTDs [9]. Furthermore, fortification
mandates are still not universally adopted, and most
countries (mainly LMICs) are not fortifying grains or
rice with folate. Consequently, the rate of actual pre-
vention of FAP-SB is only 13% [9, 24]. Therefore, also
in presence of a low number of cases of NTDs, like
those found in our report, prevention measures need
to be improved and implemented even in HICs, also
in light of the increased risks of short and long-term
morbidity and disability affecting these subjects. These
unfavorable outcomes are still highly prevalent also in
HICs [9, 19]. Thus, despite the achievement of ad-
vanced standards of care and the improvements in
neonatological management and surgical techniques
[8, 25, 26], they have been observed also in some of
our patients.
Newborns and children with NTDs need a multidis-
ciplinary approach and follow-up, involving neonatolo-
gists, neonatal surgeons, pediatric neurologists,
urologists and orthopedics, geneticists, physiatrists,
physiotherapists and neurorehabilitation therapists. Our
multidisciplinary team aims to guarantee to children and
families, an individualized care oriented to maintain nor-
mal biologic functions and social life by preserving urin-
ary and stool continence, lowering the possible infective
risk, and planning and a neurodevelopmental follow-up.
Conclusions
The awareness of the benefits of preconception folic acid
supplement is still not optimum even in HICs [23]. This
is consistent with the data of our report, which showed
a low rate/absence of folate supplement among the
mothers of our patients. Adequate medical counselling
may not reach women with unplanned pregnancies, and/
or more vulnerable owing to socio-economic status.
Since even in HICs, prenatal US screening cannot com-
pletely contain the impact on health systems that these
defects exert in relation to the burden of complex care
and morbidity/disability risks. These primary interven-
tion remains our most important and effective tool.
Thus, alternative preventive strategies should be consid-
ered. These may include fortifying commonly consumed
foods and, through public health policies, allow a free
availability of preconception folic acid supplements to all
women of childbearing age.
Neonatologists and pediatricians should claim a lead-
ing role in national and international health as well as
research policies, with the goal of preventive and cura-
tive care pertaining to disability.
Every child has the right to be protected against any
disease, even more if complex and burdened by high
morbidity and mortality. This is particularly true for
newborns with NTDs, for whom we have an extraordin-
ary potential of prevention available. If this is not
achieved, an early, multidisciplinary, individualized and
family centered as well as longitudinal management,
should be guaranteed.
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